// diabetes_biomarker_discovery.bh
// Example Buhera script demonstrating surgical precision mass spectrometry
// for diabetes biomarker discovery with explicit objective focus

import lavoisier.mzekezeke
import lavoisier.hatata  
import lavoisier.zengeza
import lavoisier.diggiden

// Define the scientific objective with explicit success criteria
objective DiabetesBiomarkerDiscovery:
    target: "identify metabolites predictive of diabetes progression with clinical utility"
    success_criteria: "sensitivity >= 0.85 AND specificity >= 0.85 AND auc >= 0.9"
    evidence_priorities: "mass_match,ms2_fragmentation,pathway_membership,retention_time"
    biological_constraints: "glycolysis_upregulated,tca_cycle_disrupted,insulin_resistance_markers"
    statistical_requirements: "sample_size >= 30, effect_size >= 0.5, power >= 0.8"

// Pre-flight validation to catch experimental flaws before execution
validate InstrumentCapability:
    check_instrument_capability
    if target_concentration < instrument_detection_limit:
        abort("Orbitrap cannot detect picomolar glucose metabolites - adjust concentration or method")

validate SampleSize:
    check_sample_size
    if sample_size < 30:
        warn("Sample size may be insufficient for robust biomarker discovery")
    if case_control_ratio < 0.5:
        warn("Unbalanced case-control ratio may bias results")

validate BiologicalCoherence:
    check_pathway_consistency
    if glycolysis_markers absent AND diabetes_expected:
        warn("Missing expected glycolysis disruption markers")

// Analysis phases with objective-directed processing
phase DataAcquisition:
    // Load data with metadata for biomarker context
    dataset = load_dataset(
        file_path: "diabetes_cohort_samples.mzML",
        metadata: "clinical_diabetes_progression_data.csv",
        groups: ["control", "prediabetic", "t2dm"]
    )
    
    // Validate data quality for biomarker discovery
    quality_check = lavoisier.validate_data_quality(dataset)
    if quality_check.mass_accuracy > 5_ppm:
        abort("Mass accuracy insufficient for metabolite identification")

phase Preprocessing:
    // Intelligent noise reduction that preserves biomarker signals
    clean_data = lavoisier.zengeza.noise_reduction(
        data: dataset,
        objective_context: "diabetes_biomarker_discovery",
        preserve_patterns: ["glucose_pathway", "lipid_metabolism", "amino_acids"]
    )
    
    // Normalize with biomarker-aware method
    normalized_data = lavoisier.preprocess(
        data: clean_data,
        method: "quantile_biomarker_aware",
        biological_context: "diabetes_progression"
    )

phase EvidenceBuilding:
    // Build evidence network already knowing what we're looking for
    evidence_network = lavoisier.mzekezeke.build_evidence_network(
        data: normalized_data,
        objective: "diabetes_biomarker_discovery",
        evidence_types: [
            "mass_match",           // Basic compound identification  
            "ms2_fragmentation",    // Structural confirmation
            "pathway_membership",   // Biological relevance
            "retention_time",       // Chromatographic confirmation
            "isotope_pattern"       // Additional confidence
        ],
        pathway_focus: ["glycolysis", "gluconeogenesis", "pentose_phosphate", "tca_cycle"],
        clinical_relevance: "diabetes_progression_markers"
    )

phase BayesianInference:
    // Validate evidence with objective-specific criteria
    annotations = lavoisier.hatata.validate_with_objective(
        evidence_network: evidence_network,
        confidence_threshold: 0.85,
        clinical_utility_threshold: 0.8,
        objective_alignment: "diabetes_biomarker_discovery"
    )
    
    // Adversarial testing to ensure robustness
    robustness_test = lavoisier.diggiden.test_biomarker_robustness(
        annotations: annotations,
        perturbation_types: ["noise_injection", "batch_effects", "concentration_drift"]
    )

phase ClinicalValidation:
    // Cross-validate biomarker candidates
    if annotations.confidence > 0.85:
        biomarker_candidates = filter_top_candidates(annotations, top_n: 20)
        
        // Test clinical utility
        clinical_performance = validate_clinical_utility(
            candidates: biomarker_candidates,
            clinical_data: "clinical_diabetes_progression_data.csv",
            validation_method: "nested_cross_validation"
        )
        
        // Generate clinically-relevant report
        if clinical_performance.auc >= 0.9:
            generate_biomarker_report(
                candidates: biomarker_candidates,
                performance: clinical_performance,
                clinical_context: "diabetes_progression_prediction"
            )
        else:
            suggest_additional_evidence(
                current_candidates: biomarker_candidates,
                missing_pathways: clinical_performance.gaps,
                improvement_strategies: "increase_sample_size,add_validation_cohort"
            )
    else:
        abort("Insufficient evidence for reliable biomarker identification")

phase ResultsSynthesis:
    // Final validation that we achieved the objective
    objective_achieved = validate_objective_completion(
        target: "diabetes_biomarker_discovery",
        results: clinical_performance,
        success_criteria: {
            "sensitivity": 0.85,
            "specificity": 0.85, 
            "auc": 0.9,
            "clinical_utility": 0.8
        }
    )
    
    if objective_achieved:
        finalize_biomarker_panel(clinical_performance)
        generate_clinical_implementation_guide()
    else:
        generate_improvement_recommendations() 